Frontiers in Oncology | Cancer Immunity and Immunotherapy

Systematic Review

Published on 17 May 2024

Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Xin Shen
Jun Yang
Geng Qian
Mingyu Sheng
Yu Wang
Guohui Li
Jiaqing Yan

Frontiers in Oncology

doi 10.3389/fonc.2024.1391724

1,394 views
3 citations

Systematic Review

Published on 16 May 2024

Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Hanyu Shen
Chunxiao Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1385761

2,019 views

Hypothesis and Theory

Published on 14 May 2024

Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer

in Cancer Immunity and Immunotherapy

Matías Muñoz-Medel
Mauricio P. Pinto
Lauren Goralsky
Mónica Cáceres
Franz Villarroel-Espíndola
Patricio Manque
Andrés Pinto
Benjamin Garcia-Bloj
Tomas de Mayo
Juan A. Godoy

Frontiers in Oncology

doi 10.3389/fonc.2024.1403089

3,338 views
3 citations

Mini Review

Published on 10 May 2024

The role of neck adipose tissue in lymph node metastasis of head and neck cancer

in Cancer Immunity and Immunotherapy

Yiqi Pan
Ying Xu
Cui Fan
Xiangwan Miao
Yilin Shen
Quan Wang
Jichang Wu
Haixia Hu
Hao Wang
Mingliang Xiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390824

1,444 views

Case Report

Published on 10 May 2024

Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

in Cancer Immunity and Immunotherapy

Dina Poplausky
Jade N. Young
Brandon R. Block
Yeriel Estrada
Giselle K. Singer
Vicky Wong
Patricia Cabral
Yamato Suemitsu
Randie H. Kim
Philip Friedlander

Frontiers in Oncology

doi 10.3389/fonc.2024.1294331

1,173 views

Case Report

Published on 10 May 2024

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

in Cancer Immunity and Immunotherapy

Weijia Wu
Jinyou Guo
Lianxiang He
Qi Deng
Xianping Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390343

1,044 views
1 citation

Case Report

Published on 10 May 2024

Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy

in Cancer Immunity and Immunotherapy

Yun Li
Yanzhen Lai
Xuqiang Luo
Jian Wu
Kunpeng Wu
Haiqing Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1291131

1,447 views

Original Research

Published on 08 May 2024

Examination of the role of mutualism in immune evasion

in Cancer Immunity and Immunotherapy

Lucie Gourmet
Simon Walker-Samuel
Parag Mallick

Frontiers in Oncology

doi 10.3389/fonc.2024.1406744

908 views
1 citation

Systematic Review

Published on 02 May 2024

The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Pengfei Zhao
Ting Zhao
Lihong Yu
Wenming Ma
Wenyu Liu
Chenning Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1381250

2,723 views
1 citation

Original Research

Published on 02 May 2024

Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer

in Cancer Immunity and Immunotherapy

Xiaonan Zhu
Yaning Feng
Peiwen Fan
Danning Dong
Jianlin Yuan
Cheng Chang
Ruozheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1381381

1,688 views
1 citation

Original Research

Published on 02 May 2024

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

in Cancer Immunity and Immunotherapy

Shuling Shi
Yingyi Wang
Jingjing Wu
Boya Zha
Peihong Li
Yukun Liu
Yuchuan Yang
Jinglin Kong
Shibo Gao
Haiyang Cui

Frontiers in Oncology

doi 10.3389/fonc.2024.1342262

1,408 views

Original Research

Published on 01 May 2024

High immune cell infiltration predicts improved survival in cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Erkki-Ville Wirta
Säde Szeto
Hanna Koppatz
Arno Nordin
Heikki Mäkisalo
Johanna Arola
Jukka Sirén
Maarit Ahtiainen
Jan Böhm
Jukka-Pekka Mecklin

Frontiers in Oncology

doi 10.3389/fonc.2024.1333926

1,359 views
2 citations

Original Research

Published on 29 Apr 2024

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

in Cancer Immunity and Immunotherapy

Diana C. Lopez
Kellsye P. Fabian
Michelle R. Padget
Yvette L. Robbins
Joshua T. Kowalczyk
Wiem Lassoued
Danielle M. Pastor
Clint T. Allen
Gary L. Gallia
James L. Gulley

Frontiers in Oncology

doi 10.3389/fonc.2024.1376622

2,153 views

Editorial

Published on 15 Apr 2024

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

in Cancer Immunity and Immunotherapy

Anand Rotte

Frontiers in Oncology

doi 10.3389/fonc.2024.1404376

843 views

Review

Published on 10 Apr 2024

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yan Lu
Bo Lin
Mengsen Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1363695

2,712 views
4 citations

Case Report

Published on 05 Apr 2024

Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case report

in Cancer Immunity and Immunotherapy

Tao Wang
Fei Tang
Fenghui Li
Weili Yin
Jing Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1321195

1,072 views

Navigation group

Articles

Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis

Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis

Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer

The role of neck adipose tissue in lymph node metastasis of head and neck cancer

Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC

Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy

Examination of the role of mutualism in immune evasion

The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis

Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer

Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models

High immune cell infiltration predicts improved survival in cholangiocarcinoma

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

Editorial: Emerging learnings in cell therapy: novel binding domains, universal CAR-T cells, and more

The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma

Retreatment with immunotherapy in a patient with hepatocellular carcinoma who received immune checkpoint inhibitors after primary curative treatment: a case report